July 2023

Includes: Making a personalized list of health/medical info, Treatment intensification in advanced prostate cancer lags behind data, New guidelines for early detection, and more!

March 2023

Includes: Prostate Cancer ADT Increases Bone Fracture Risk, Testosterone Therapy, Improving Survival in Black Patients, Advanced Prostate Cancer on the rise, Cal Ripken Jr. on PC, and more!

Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer

PROSTAID Calgary’s 2022 Pathfinder Award went to Dr. Geoffrey Gotto, who presented on new research and innovations in metastatic castration-sensitive prostate cancer (MCSPC) that is leading to longer survival and greater quality of life in prostate cancer patients who do combinations of treatments to combat the cancer.